Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
about
Small cell lung cancer (SCLC): no treatment advances in recent yearsCancer stem cells in small cell lung cancerNovel therapies in small cell lung cancerGenomic profiling of small-cell lung cancer: the era of targeted therapiesKlotho sensitizes human lung cancer cell line to cisplatin via PI3k/Akt pathwayPTEN is a potent suppressor of small cell lung cancer.Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry.Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85alpha Src homology-2 domainsUpregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patientsComprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours.Comprehensive genomic profiles of small cell lung cancer.The Biological Role of PI3K Pathway in Lung Cancer.MET and Small-Cell Lung Cancer.KH-type splicing regulatory protein (KHSRP) contributes to tumorigenesis by promoting miR-26a maturation in small cell lung cancer.Update on large cell neuroendocrine carcinoma.Small-cell lung cancer: what we know, what we need to know and the path forward.The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.Expression of a splicing variant of the CADM1 specific to small cell lung cancer.EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients.Advanced small cell lung cancer (SCLC): new challenges and new expectations.[Advances on Driver Mutations of Small Cell Lung Cancer].
P2860
Q26767020-7B82F514-88DF-4C94-AD1F-89D1847B1FBFQ26767026-3CEE08FA-BD6D-4DEC-B703-AEAFC1AC78B3Q26775390-18D74E03-D5DD-4B0F-A2C3-9A3C04AB37EFQ26826915-2084540A-256C-4A6B-9463-A54A16786C2CQ28486480-C1C5221B-BC8C-4A76-AEC4-F87A51777F4BQ33610833-5A6F6EF2-A93C-4CD6-945A-0F368A0F39D8Q35005185-A87B3898-D602-4BBD-A3E3-1BC1A5528E8CQ35180699-98DDC685-8676-481E-BCEC-D66D5FE707D8Q35342968-4442D688-3FFB-450A-8C00-A23F9C64B06AQ36568988-C872C355-380D-45F1-A9B1-44C4DDBB6F5DQ36642695-6736A821-A2D5-4EE5-9A69-0292A7FF58B4Q36883530-68F02BDD-75EB-4D9B-ABC0-BA2A0EEC17D4Q38166599-272D8A09-1C24-4ACF-8F47-0810C6189C85Q38260120-FDCF3255-0EBB-46EB-947C-220236E5D0BDQ38745227-6F7466F3-2569-4D60-B1CB-600C377B0797Q46316777-82C2491C-807D-4667-B670-B3B7C9147425Q47595394-166B3000-E9A3-48BA-8994-0CF76849DB1DQ47868509-5F64B976-F770-42E1-AAE6-6C8EE9E0BC52Q53178939-50742C54-91DE-49EF-9E98-A9C6015C79E1Q54222458-28B1B2B8-C0DA-437E-BC94-EA5FDBA47572Q54977232-8BD54C25-9400-4208-9DE0-F43E1C512F9FQ55464542-99FB2B3F-9939-4DC0-ADA1-289BB0FABDD7
P2860
Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Oncogenic mutation of PIK3CA i ...... therapy-resistant lung cancer.
@en
Oncogenic mutation of PIK3CA i ...... therapy-resistant lung cancer.
@nl
type
label
Oncogenic mutation of PIK3CA i ...... therapy-resistant lung cancer.
@en
Oncogenic mutation of PIK3CA i ...... therapy-resistant lung cancer.
@nl
prefLabel
Oncogenic mutation of PIK3CA i ...... therapy-resistant lung cancer.
@en
Oncogenic mutation of PIK3CA i ...... therapy-resistant lung cancer.
@nl
P2093
P1433
P1476
Oncogenic mutation of PIK3CA i ...... therapy-resistant lung cancer.
@en
P2093
Akiko Kokubu
Koji Tsuta
Setsuo Hirohashi
Tatsuhiro Shibata
P304
P356
10.1016/J.CANLET.2009.03.038
P407
P577
2009-04-25T00:00:00Z